COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,941 Articles (22,604 medRxiv, 8,337 bioRxiv)

Most recent first Previous |  Page 1317: Articles 13161-13170  | Next

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in ferrets
Lehtinen, M., Kumar, R., Zabel, B., Makela, S. M., Nedveck, D., Tang, P., Latvala, S., Guery, S., Budinoff, C. R.
10.1101/2021.07.23.453521 — Posted: 2021-07-23
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
Alvarado, D. M., Son, J., Thackray, L. B., Diamond, M., Ding, S., Ciorba, M. A., Washington University IBD Investigators Group
10.1101/2021.07.23.453393 — Posted: 2021-07-23
The in vitro and in vivo potency of CT-P59 against Delta and its associated variants of SARS-CoV-2
Ryu, D.-K., Woo, H.-M., Kang, B., Noh, H., Kim, J.-I., Seo, J.-M., Kim, C., Kim, M., Kim, J.-W., Kim, N., Jeon, P., Lee, H., Yang, J.-S., Kim, K.-C., Lee, J.-Y., Lee, M.-H., Oh, S.-S., Chung, H.-Y., Kwon, K.-S., Lee, S.-Y.
10.1101/2021.07.23.453472 — Posted: 2021-07-23
Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.
Diez, J.-M., Romero, C., Gajardo, R.
10.1101/2021.07.23.453571 — Posted: 2021-07-23
Understanding the role of memory re-activation and cross-reactivity in the defense against SARS-CoV-2
Denninger, V., Xu, C. K., Meisl, G., Morgunov, A. S., Fiedler, S., Ilsley, A., Emmenegger, M., Malik, A. Y., Piziorska, M. A., Schneider, M. M., Devenish, S. R. A., Kosmoliaptsis, V., Aguzzi, A., Fiegler, H., Knowles, T. P. J.
10.1101/2021.07.23.453352 — Posted: 2021-07-23
PDZ-containing proteins targeted by the ACE2 receptor
Caillet-Saguy, C., Wolff, N.
10.1101/2021.07.23.453470 — Posted: 2021-07-23
A Highly Potent SARS-CoV-2 Blocking Lectin Protein
Ahan, R. E., Hanifehnezhad, A., Sahin Kehribar, E., Oguzoglu, T. C., Foldes, K., Ozcelik, C. E., Filazi, N., Oztop, S., Onder, S. C., Bozkurt, E. U., Ergunay, K., Ozkul, A., Seker, U.
10.1101/2021.07.22.453309 — Posted: 2021-07-23
SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry into Alveolar Epithelium
Giancotti, F., Wang, Y., Gurrapu, S., Chen, H., Laudato, S., Caggiano, E., Jiang, Y., Ling, H.-H.
10.1101/2021.07.23.453505 — Posted: 2021-07-23
Time trends and factors related to COVID-19 vaccine hesitancy from January-May 2021 among US adults: Findings from a large-scale national survey
King, W. C., Rubinstein, M., Reinhart, A., Mejia, R. J.
10.1101/2021.07.20.21260795 — Posted: 2021-07-23 Discussion: Onsite
The COVID-19 pandemic and child malnutrition in sub-Saharan Africa: A scoping review
Sesito, P., Rodriguez Velasquez, S., Orel, E., Keiser, O.
10.1101/2021.07.21.21260929 — Posted: 2021-07-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).